CLINICAL_TRIALS
trial_result
· 2024-08-15
Clinical Trial Update: Docetaxel With or Without AZD6244 in Melanoma [Phase 2]
Summary
Phase 2 trial evaluating docetaxel with or without the MEK inhibitor AZD6244 in melanoma has completed, and the results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Oxford | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2024-08-15